BPA Call 36E79722A0026-36C24526N0739
Award Date 7/21/26
Potential Completion Date 7/23/26
Potential Value $105K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
Not listed Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Carrollton, TX 75010, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Alexion Pharmaceuticals Inc. was awarded a delivery order valued at $1.26M by Veterans Integrated Service Network 20 for the supply of STRENSIQ 80 mg/0.8 mL injectable medication, including a 2026 price increase provision. The contract is firm fixed price with no set-aside designation, reflecting open competition procurement. This delivery order was awarded on December 22, 2025, with an ultimate completion date of December 21, 2026, and will be performed at Alexion's facility in Carrollton,...
- Alexion Pharmaceuticals Inc., a Boston-based biopharmaceutical company specializing in rare disease therapeutics, has been awarded a delivery order valued at $626,866.08 by Veterans Integrated Service Network 20 for the supply of Strensiq, a specialized injectable medication used to treat hypophosphatasia, a rare genetic disorder. This delivery order, issued on December 22, 2024, with an ultimate completion date of December 21, 2025, operates under a firm fixed-price structure with no...
- The Defense Logistics Agency awarded a delivery order valued at $70,012.80 to AmerisourceBergen Drug Corp for the supply of STRENSIQ 80 mg/0.8 mL vials. The contract is structured as a firm fixed price delivery order with an ultimate completion date of November 13, 2025, and represents a non-competitive set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. This delivery order is issued under the company's...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a foreign-owned, for-profit biotherapeutics company. The contract is for the supply of 5 gram vials of the immune globulin drug Privigen. The BPA call has a ceiling value of $84,903.00 and was awarded under CSL Behring's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which has a total ceiling value of...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Department of Veterans Affairs (VA) to Actelion Pharmaceuticals US, Inc., a large pharmaceutical manufacturer. The contract, valued at $258,159.26, is for the express procurement of pharmaceutical orders through the VA's National Acquisition Center to support the VA's Pharmacy Service Network 19 (VISN 19). The contract is not set aside for any specific business category. This BPA call is a part of Actelion's...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VHA VISN 8) awarded a Blanket Purchase Agreement (BPA) Call against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) to CSL Behring L.L.C. The BPA has a potential value of $136,441.88 and a completion date of August 31, 2020. Place of performance will be in King of Prussia, Pennsylvania. As a BPA Call off the larger GSA Pharmaceuticals and Drugs Schedule, this contract...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VHA VISN 8) awarded CSL Behring L.L.C. a Blanket Purchase Agreement (BPA) Call against the Pharmaceuticals and Drugs Government-Wide Acquisition Contract (FSS-61-IB) for an estimated $136,409.05. The BPA Call has a completion date of October 24, 2020 and was awarded on August 20, 2020 under firm fixed pricing terms. Place of performance will be in King of Prussia, Pennsylvania. No set-aside...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded CSL Behring L.L.C. a blanket purchase agreement (BPA) call against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) master contract. The BPA call has a potential value of $25,213.77 and requires delivery of unspecified pharmaceutical or drug products to locations in King of Prussia, Pennsylvania under firm fixed price terms by April 30, 2020. No set-aside designation...
- This is a federal contract award to Actelion Pharmaceuticals US, Inc., a large pharmaceutical manufacturer, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 20. The contract is for the delivery of the drug Selexipag (Uptravi), a treatment for pulmonary arterial hypertension. The contract has a ceiling value of $70,629.56 and is a firm-fixed-price delivery order with an ultimate completion date of August 7, 2025. The contract is not set aside for small businesses....
- This Blanket Purchase Agreement (BPA) call was awarded under the Department of Veterans Affairs' (VA) Veterans Integrated Service Network 8's (VISN 8) master GSA Schedule contract for pharmaceuticals and drugs. CSL Behring L.L.C. will deliver $25,227.62 worth of Privigen 675A00060, a human plasma-derived intravenous immunoglobulin product, on a firm fixed price basis to locations in King of Prussia, Pennsylvania. No set-aside designation was applied to this BPA call issued under the VA's...